Literature DB >> 29243863

Synthesis and antioxidant, antixanthine oxidase, and antielastase activities of novel N,S-substituted polyhalogenated nitrobutadiene derivatives.

Nihal Onul1, Onur Ertik2, Nese Mermer1, Refiye Yanardag2.   

Abstract

In this study, three substituted polyhalogenated nitrobutadiene derivatives were synthesized. Compound 1-[(2,3-dibromopropyl)sulfanyl]-1,3,4,4-tetrachloro-2-nitrobuta-1,3-diene (4) was synthesized before by our group. Compounds 8-{[1-[(2,3-dibromopropyl)sulfany]-3,4,4-trichloro-2-nitrobuta-1,3-butadien-1-yl}-1,4-dioxa-8-azaspiro[4.5]decane (5) and 1-[(2,3-dibromopropyl)sulfanyl]-3,4,4-trichloro-N-(4-methylpiperazin-1-yl)-2-nitrobuta-1,3-diene-1-amine (6) were synthesized in this work as original compounds. Xanthine oxidase, elastase inhibition abilities, and antioxidant activities were investigated in this work for compounds 4, 5, and 6. In this study, compounds 4, 5, and 6 exhibited antixanthine oxidase, antielastase, and antioxidant activities. Among the compounds screened, compound 4 exhibited xanthine oxidase and elastase inhibitor effect similar to the standard compound. Among the three tested compounds, compound 6 showed potent DPPH radical scavenging and reducing power activities. Therefore, these three compounds (4, 5, and 6) may be useful as an antixanthine oxidase, antielastase, and antioxidant agent in pharmaceutical and cosmetic industry.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  2-Nitroperchlorobutadiene; antielastase; antioxidant; antixanthine oxidase; heterocyclic amines

Mesh:

Substances:

Year:  2017        PMID: 29243863     DOI: 10.1002/jbt.22021

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  1 in total

1.  Novel palladium (II) complexes with tetradentate thiosemicarbazones. Synthesis, characterization, in vitro cytotoxicity and xanthine oxidase inhibition.

Authors:  Dilşad Özerkan; Onur Ertik; Buşra Kaya; Serap Erdem Kuruca; Refiye Yanardag; Bahri Ülküseven
Journal:  Invest New Drugs       Date:  2019-03-14       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.